Diabetes injection technique guidelines updated
Guidelines on diabetes injection techniques have been updated so healthcare professionals can issue the new advice to their patients.
The Forum for Injection Technique (FIT) UK, which provides evidence-based best practice recommendations on diabetes injection technique, has published the latest edition of its UK Injection and Infusion Technique Recommendations.
The fourth edition of the document covers key aspects of injection technique, such as the importance of using short pen needles, recommended injection sites, and how to avoid lipohypertrophy. For the first time a set of six golden rules for people to follow have been also been included, along with guidance on the psychological challenges of injections, therapeutic education, and injection safety.
The newly issued golden rules, which include treating and preventing lipohypertrophy and advice on sharp disposal, have also been published as a separate booklet. They have been specifically designed as an easy-to-read reminder of best practice injection technique to help clinicians care for people with diabetes that use injectable therapies throughout the UK.
FIT UK board chair Debbie Hicks said: “For those people with diabetes using injectable therapies, best practice injection technique is a crucial element of condition management as it is essential for therapies to achieve their optimal effect. Poor technique can lead to injectable therapies being absorbed in an unpredictable manner, and immediate problems such as hypoglycaemia and hyperglycaemia may result.
“In the longer term, poor glycaemic control can increase the risk of complications including kidney failure, blindness and limb amputation.
“Best practice injection technique has the ability to reduce hypoglycaemic episodes and encourage glycemic stability, and FIT’s overarching mission is to support people with diabetes using injectable therapies to achieve the best possible health outcomes that are influenced by correct injection technique.
These recommendations are designed to help ensure that the correct prescribed dose of medication is delivered to the correct injection site, using the correct technique, thus helping to avoid diabetes related complications.”
FIT UK’s recommendations were updated following the Forum for Injection Technique & Therapy Recommendations (FITTER) congress, which was held in Rome in 2015.
At the event, international FITTER recommendations were created by a group of 183 diabetes experts from 54 countries, based on findings of the largest ever injection technique survey, which took place from February to June 2015, and involved over 13,200 participants from 42 countries.
Diabetes UK estimates that more than one in 16 people in the UK have diabetes (diagnosed or undiagnosed) and that there are four million people living with diabetes in the UK, a figure which is projected to rise to five million people by 2025.